TITLE

Structural properties of polysaccharide-based microcapsules for soft tissue regeneration

AUTHOR(S)
Munarin, F.; Petrini, P.; Farè, S.; Tanzi, M. C.
PUB. DATE
January 2010
SOURCE
Journal of Materials Science: Materials in Medicine;Jan2010, Vol. 21 Issue 1, p365
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Autologous and eterologous cell encapsulation has been extensively studied for clinical application in functional organs substitution, recombinant cell transplantation in gene therapy or in muscle and cartilage regeneration to treat degenerative pathologies. In this work, calcium alginate, calcium alginate/chitosan, calcium alginate/gelatin and pectin/chitosan microcapsules were prepared to be used as innovative injectable scaffolds for soft tissue regeneration by a simple extrusion method from aqueous solutions. Prepared microcapsules had spherical morphology, whereas their size was deeply influenced by the polymeric composition. When incubated in a physiological-like environment up to 30 days, they underwent an initial swelling, followed by weight loss at different rates, depending on the microcapsules formulation. The encapsulation of mouse myoblast cells (C2C12 cell line) was obtained in calcium alginate, calcium alginate/chitosan, calcium alginate/gelatin microcapsules. Cells were alive throughout the encapsulation procedure, and were recovered by a mechanical rupture of the microcapsules. After 7 days, fractured microcapsules led cells to migrate gradually out.
ACCESSION #
47481431

 

Related Articles

  • Treatment of growth plate injury with microencapsulated chondrocytes. Li, Wen-Chao; Xu, Rui-Jiang; Xue, Yi-Long; Huang, Jing-Xiang; Gao, Yu-Hong // Biotechnology & Bioprocess Engineering;Jul2013, Vol. 18 Issue 4, p655 

    Background: Tissue-engineered cartilage has provided a promising method in the treatment of physeal growth arrest. This study was designed to investigate transplantation of microencapsulated allogeneic chondrocytes to treat the injured growth plate. Methods: Allogeneic chondrocytes were...

  • Chitosan Composites for Bone Tissue Engineering-An Overview. Venkatesan, Jayachandran; Se-Kwon Kim // Marine Drugs;Aug2010, Vol. 8 Issue 8, p2252 

    Bone contains considerable amounts of minerals and proteins. Hydroxyapatite [Ca10(PO4)6(OH)2] is one of the most stable forms of calcium phosphate and it occurs in bones as major component (60 to 65%), along with other materials including collagen, chondroitin sulfate, keratin sulfate and...

  • Transplantation-Based Gene Therapy for Inflammatory Diseases Focus on Glomerulonephritis. Yokoo, T.; Ohashi, T. // Current Gene Therapy;Jul2001, Vol. 1 Issue 2, p227 

    Over the past decade, bone marrow transplantation has come to be considered an ideal therapeutic strategy for the treatment of certain diseases affecting the hematopoietic system such as hemophilia, and several clinical trials have Been performed. Although traditionally used for the treatment of...

  • Gene therapy in transplantation in the year 2000: moving towards clinical applications? Guillot, C; Le Mauff, B; Cuturi, M C; Anegon, I // Gene Therapy;Jan2000, Vol. 7 Issue 1, p14 

    Transplantation faces several major obstacles that could be overcome by expression of immunomodulatory proteins through application of gene therapy techniques. Gene therapy strategies to prolong graft survival involve gene transfer of immunosuppressive or graft-protecting molecules. Very...

  • Journal of Knee Surgery: Storage time for cartilage transplant tissue doubled by MU researchers.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article presents information on a study related to the storage of donated cartilages for transplantation.

  • The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Niyibizi, Christopher; Wang, Sujing; Mi, Zhibao; Robbins, Paul D. // Molecular Therapy;Jun2004, Vol. 9 Issue 6, p955 

    To explore the feasibility of skeletal gene and cell therapies, we transduced murine bone marrow-derived mesenchymal stem cells (MSCs) with a retrovirus carrying the enhanced green fluorescent protein and zeocin-resistance genes prior to transplantation into 2-day-old immunocompetent neonatal...

  • Walking before running.  // Nature Immunology;May2002, Vol. 3 Issue 5, p409 

    Focuses on various advancements made in the field of medicine. Conflict of opinion among the scientific community regarding gene therapy; Complications associated with transplantation of cells, tissues and organs.

  • Parkinson's disease: Progress along the continuum of care. Pennachio, Dorothy L. // Patient Care for the Nurse Practitioner;Dec2000, Vol. 3 Issue 12, p26 

    Focuses on the prevention of Parkinson's disease. Details on differential diagnosis; Options for treatment and surgery; Discussion on fetal cell transplants and gene therapy.

  • THE SCIENCE OF TRANSPLANTATION: A CONSTANTLY EVOLVING FRONTRUNNER IN MEDICINE. Jedrzejczak, Wieslaw W. // Dialogue & Universalism;2000, Vol. 10 Issue 7/8, p41 

    Examines the possibilities of transplantation techniques on the organ, cellular, and genetic level in the context of public misunderstanding of this field of medicine. Transplantation of the brain; Types of gene therapy; Cell transplantation procedures.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics